Literature DB >> 33726001

Difference in the efficacy of intravitreal dexamethasone implant before and after silicone oil removal: A case report.

Jae Hong An1, Yu Cheol Kim.   

Abstract

RATIONALE: An intravitreal dexamethasone (IV-DEX) implant is safe and effective for the treatment of macular edemas; however, the efficacy of IV-DEX implants in silicone oil (SO)-filled eyes remains controversial. There is no previous study comparing an IV-DEX implant in the same eye with and without intravitreal SO. PATIENT CONCERNS: A 72-year-old man with proliferative diabetic retinopathy, macular edema, and rhegmatogenous retinal detachment, treated with pars plana vitrectomy with SO tamponade had refractory macular edema. DIAGNOSIS: Refractory macular edema. INTERVENTION: Subtenon triamcinolone injection, intravitreal anti-vascular endothelial growth factor injection, and IV-DEX implantation were performed; this was followed by intravitreal SO removal combined with IV-DEX implantation. OUTCOMES: The macular edema did not decrease significantly with posterior subtenon triamcinolone injection, intravitreal anti-vascular endothelial growth factor injection, and IV-DEX implantation; however, the edema was relieved after SO removal and a new IV-DEX implantation. LESSONS: IV-DEX implant may be less efficacious in the treatment of macular edema in an SO-filled eye than that in a normal vitreous cavity.
Copyright © 2021 the Author(s). Published by Wolters Kluwer Health, Inc.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33726001      PMCID: PMC7982211          DOI: 10.1097/MD.0000000000025161

Source DB:  PubMed          Journal:  Medicine (Baltimore)        ISSN: 0025-7974            Impact factor:   1.817


  6 in total

1.  Dexamethasone intravitreal implant trapped at the macula in a silicone oil-filled eye.

Authors:  Armin R Afshar; Allison R Loh; Pear Pongsachareonnont; Daniel M Schwartz; Jay M Stewart
Journal:  Ophthalmology       Date:  2013-12       Impact factor: 12.079

2.  Dexamethasone intravitreal implant in the silicone oil-filled eye for the treatment for recurrent macular oedema associated with ankylosing spondylitis: a case report.

Authors:  Jee T Kim; Young H Yoon; Dong H Lee; Soo G Joe; June-G Kim
Journal:  Acta Ophthalmol       Date:  2013-02-11       Impact factor: 3.761

3.  Safety of 6000 intravitreal dexamethasone implants.

Authors:  Bindu Rajesh; Javier Zarranz-Ventura; Adrian T Fung; Catharina Busch; Niroj Kumar Sahoo; Patricio J Rodriguez-Valdes; Valentina Sarao; Sanjay Kumar Mishra; A Osman Saatci; Patricia Udaondo Mirete; Giuseppe Querques; Michel Eid Farah; Paolo Lanzetta; J Fernando Arevalo; Laurent Kodjikian; Jay Chhablani
Journal:  Br J Ophthalmol       Date:  2019-04-30       Impact factor: 4.638

4.  Location of a Dexamethasone Implant at the Macula after Intravitreal Injection in a Silicone Oil-Filled Eye.

Authors:  Cenap Mahmut Esenulku; Murat Gunay
Journal:  Case Rep Ophthalmol Med       Date:  2016-11-23

5.  Intravitreal dexamethasone implant Ozurdex® in naïve and refractory patients with different subtypes of diabetic macular edema.

Authors:  Verónica Castro-Navarro; Enrique Cervera-Taulet; Catalina Navarro-Palop; Clara Monferrer-Adsuara; Laura Hernández-Bel; Javier Montero-Hernández
Journal:  BMC Ophthalmol       Date:  2019-01-11       Impact factor: 2.209

6.  Dexamethasone implant in silicone oil: in vitro behavior.

Authors:  Erick Omar Flores-Villalobos; J Abel Ramírez-Estudillo; Atzin Robles-Contreras; Jacqueline L Oliva-Ramírez
Journal:  Int J Retina Vitreous       Date:  2018-06-20
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.